Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference

Bexotegrast clinical poster selected for featured oral presentation at ATS 2024 Mini Symposium SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced that the Company will present four scientific posters at the upcoming 2024 American Thoracic Society (ATS) International Conference, takin

Related Keywords

San Diego Convention Center ,California ,United States ,San Diego ,American ,Martinl Decaris ,Christopher Keenan ,Gregoryp Cosgrove ,Los Angeles ,Jonathang Goldin ,Nasdaq ,Clinical Development ,Pliant Therapeutics Inc ,International Conference ,University Of California ,Youtube ,European Medicines Agency ,David Geffen School Of Medicine ,Corporate Communications ,Linkedin ,American Thoracic Society ,Drug Administration ,Translational Sciences ,Facebook ,Thoracic Society ,Senior Director ,Unveiling Novel Avenues ,Principal Scientist ,New Therapeutics Targets ,Upper Level ,Biomedical Physics ,David Geffen School ,Machine Learned ,Driven Solutions ,Vice President ,New Clinical Trial Results ,Chronic Lung ,Pliant Therapeutics ,Fast Track Designation ,Orphan Drug Designation ,Media Contact ,Investor Relations ,